Abstract:Let us take two groups of, say, 310 people each, drawn from the same population. Now let usdraw two large circles. Withineachcircle, let usdraw31 equallyspacedsmallercircles, sothat,foreachsmallcircleinonelargecircle, thereisan equivalently situated small circle in the other large circle. Now we instruct the 31 0 people to form self-assorted subgroupsof lopeopleeach, andoccupyoneofthesmallcircles. We measure everyone's height, weight, neckcircumference, and abdominal girth. Now we take the mean height, weight, neckcircumference and abdominal girth at each small circle. The next step comprises a comparison of each small circle within one large circle, with the equivalent small circle in the otherlargecircle.Thus,we have31 x4= 124comparisons. If wesetourpvalueforsignificantdifferenceatO.05, we will find, onaverage, 124x0.05= Gsignificantdifferences. Forexample, we might find that circle D1 has a smaller height and weight, circles A1 and F1 have a larger neckcircumference, circle K1 has a larger abdominal girth, and circle 0 1 has a smaller abdominal girth. What are we to make of this data? Wecouldconclude thatthere isadifferencein the mapping of, say, theneckcircumference, withcircle 1 showing largercircumference at A1 and F1. Yet, a test for overall statistically significant difference would probably find that there are no real differences here. Going further, we could draw topographical maps of the abdominal girth, assigningdifferentcolors to differentvalues. Ifavalueof30"isblue,32"isgreen,34'isyellow,andsoon, we might find some areas to be yellow on map 1 and blue on map2. Even though theseareasshownostatisticallysignificant difference, we might state that, descriptively, there are topographical differences between the two maps. However, in the absence of demonstrated overall statistically significant difference, the descriptive topographical differences are no more than expected by chance. If we want to be rigorous, what could we do? First and foremost, we could identify a single statistical test for overall significance of topographical distribution. Although there are several possible single statistical tests, a Multivariate Analysis of Variance (MANOVA)' may bea particularly useful test. If this testshowsasignificant difference, wecouldanalyzethedata further. If this test shows no significant difference, we could stop there. Further statistical analyses and furtherdescriptions of topography in theabsenceof demonstratedoverall statistically significant difference may only invite disbelief. If we do find an overall significant statistical difference, and want to describe the topographical difference, then the description should also be based on statistically significant differences after adjusting for multiple comparisons. We could use a correction such as Bonferroni or Tukey's, or we could perform a descriptive statistical analysis such as described byAbL2 Further, we should not hide behind a small n (sample size) when thetest showsnosignificantdifference.True, the small n may maska true difference. The answer is to repeat the study with a larger n, and not to make speculative suggestions based on the non-significant difference seen with the smallern. Rigorous demonstration of overall statistically significant difference before we make suggestions or conclusions from data, may improve the acceptance of potentially revolutionary neurophysiological digital analytic and brain mapping techniques in clinical medicine.

Effects of Different Concentration of Astragalus Membranaceus Injections on Human Sperm Motility Parameters in Vitro

Comparison Between the Results of ICSI with Fresh and with Frozen-thawed Sperm Obtained by PESA to Treat Azoospermia

Improvement of Astragalin on Spermatogenesis in Oligoasthenozoospermia Mouse Induced by Cyclophosphamide

Experimental Study on Shengjingsan Recipe for the Treatment of Asthenozoospermia of Rat Model

Studies on improving semen quality and increasing pregnancy chances through the in vitro addition of L-carnitine and coenzyme Q10 to semen in patients with asthenozoospermia

Novel combination with maca improves sperm parameters in vitro of asthenozoospermic men

Scriptaid is a prospective agent for improving human asthenozoospermic sample quality and fertilization rate in vitro

[Effects of Semen Analysis on Human Sperm Movement Parameters at Different Times after Semen Collection].

The effects of L-carnitine and fructose in improved Ham's F10 on sperm culture in idiopathic severe asthenospermia within 24h

Low Dose Androil on the Treatment of Asthenospermia (Report of 41 Cases)

In vitro and in vivo investigation of the therapeutic mechanism of Lycium Chinense and Cuscutae Semen on oligoasthenozoospermia

[Compound Amino Acid Combined with Vitamin E for Idiopathic Asthenospermia].

[Experimental Study for the Treatment of Asthenozoospermia by Electroacupuncture in Rats]

Using AFM to Observe Sperm's Ultrastructures in Rats with Asthenospermia Before and after Treatment with New Chinese Medicine Optimized Formula

Conclusions from Brain Mapping: Need for Statistical Rigor

Clinical effects of Xianlu oral liquid in the treatment of idiopathic asthenozoospermia

Down-regulation of CatSper1 Channel in Epididymal Spermatozoa Contributes to the Pathogenesis of Asthenozoospermia, Whereas Up-Regulation of the Channel by Sheng-Jing-San Treatment Improves the Sperm Motility of Asthenozoospermia in Rats.

Study on establishment of rat model with asthenospermic and melioration of asthenospermic treated by L-carnitine

The potential hazards of using iodine as an antiseptic solution

Roles of CatSper channels in the pathogenesis of asthenozoospermia and the therapeutic effects of acupuncture-like treatment on asthenozoospermia

Effects of treatment with Astragalus Membranaceus on function of rat leydig cells